ME-143

· MEI Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ME-143, covering 2013-06-24 to 2013-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors [Phase 1]

See pricing